News
Gilman elected President of NETRF Board of Directors
The Neuroendocrine Tumor Research Foundation elected Todd Gillman as President of its Board of Directors at the January 2022 meeting. Gillman replaces longtime president Joseph Li, MD.
New Clinical Trial Focuses on Targeted Alpha-Emitter Therapy of PRRT
A new phase II clinical trial is evaluating the safety and effectiveness of 212Pb-DOTAMTATE in patients who have somatostatin receptor-expressing neuroendocrine tumors but who have not received peptide receptor radionuclide therapy, or PPRT.
NETRF receives $5 million from the Margie & Robert E. Petersen Foundation
The Neuroendocrine Tumor Research Foundation received a $5 million endowment gift from The Margie and Robert E. Petersen Foundation. This $5 million gift brings NETRF’s 2021 fundraising total to $7.26 million to fund NET research around the globe.
Suzanne Ludlow Joins NETRF Board of Directors
NETRF elects Suzanne Ludlow to its Board of Directors. Suzanne first became involved with NETRF after her late husband Vince’s journey with neuroendocrine cancer. Read more.
Turning the Page on 2021 with a Heartfelt Thank You
NETRF’s 2021 accomplishments were possible because of you! With the support of our donors, NET researchers, and the patient community, we had a successful year that surpassed our expectations. Thank you for your wonderful generosity.
NETRF Accelerates Research into Treatments for Neuroendocrine Cancer with $4.1 Million in Awards
BOSTON, Mass. – The Neuroendocrine Tumor Research Foundation (NETRF) today announced $4.1 million in neuroendocrine tumor (NET) research funding to support the development of new
Monthly Giving Program
In 2021, we received over $20,000.00 from 28 donors in NETRF’s Monthly Giving Program! This is an excellent way for donors who want to stay connected to a loved one’s memory, or for those who want to make a larger donation and pay it over time.
Grant Opportunities Announcement
Submit Letters of Intent by March 7, 2022 The Neuroendocrine Tumor Research Foundation (NETRF), Boston, Massachusetts, has released its 2022 Request for Applications. We invite
The 2021 Virtual NET Research Symposium – Summary/Recap
The fourteenth annual NETRF Research Symposium successfully concluded last month with over 300 registered virtual attendees participating from around the globe for the second year in a row. The meeting included nearly 60 talks and posters representing the cutting edge of NET research where investigators reported their latest data and discoveries to share and discuss with colleagues. This year posters were available for viewing over the three days preceding the two-day meeting, resulting in over 300 poster views and ample time for discussions. Over 95% of registrants attended the two-days of talks and live discussions while the recorded talks and posters were viewed by over 100 more attendees over the following week.
NETRF Announces Changes to its Board of Scientific Advisors
Dr. Thirlwell, the Mireille Gillings Professor of Cancer Genomics at the University of Exeter Medical School will assume the role in January of 2022. She is internationally renowned for advancing NET research, the clinical management of NETs and the integrated genomic analysis of cancer.